Uptrend Under Pressure 93
Institutional selling is building — 7 distribution days in the last 25 sessions. Severe risk · 93/100 · 7 distribution days (SPY) Sep 11 Full briefing →
View
Simple research view

EW · Edwards Lifesciences Corporation

$86.77 +0.68% Sep 10 close
Detected setup Trend Only · Setup Score 53/100

Stand aside — setup invalidated

Setup score 53, but distribution days reach 5 or more — stand aside until the condition resets.

Ask about EW

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$EW

Edwards Lifesciences Corporation

Edwards Lifesciences Corporation is a large-cap Medical Specialties company in the Health Technology sector with a market cap of $50B.

Health Technology Medical Specialties stock Stage 2 · Advancing Base 2
$86.77 latest close
Historical record

No active setup in the latest scan — this page shows the last detection Legend AI made for $EW. Every level, score and criterion below is computed from the Sep 10 close session (1 session old), and may no longer hold.

Historical verdict · setup score 53/100 · data Sep 10 close · 1 session old

Stand aside — setup invalidated

Setup score 53, but distribution days reach 5 or more — stand aside until the condition resets.

Earnings

Normal technical setup

No sourced report date Event risk is not modelled for this symbol

Deterministic evidence

EW+0.68%
Sector proxy · XLV-0.55%
Broad market · SPY-0.60%
Same completed session window ending 2026-09-10. EW was +1.23 points vs XLV. +1.28 points vs SPY.

Session internals Strong momentum

Rule: closed up, at or above the open, in the top third of the day's range. Judged on internals, not on the size of the move.

Vs prior close+0.68% From the open+0.90% Range position78% GapNo gap
QQQ confirmationDiverging (-1.06%) SMH confirmationDiverging (-2.44%)
Short-term conviction -1 points.
  • QQQ, SMH moved against the stock — no index confirmation.
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $86.77 +0.7% Sep 10 close
52W High $96.29 6.6% below high
Wks Since High 8w 9w today
Base Depth 13.2% 15.7% today
RS Rank 3 percentile of scan
SMA 50 $89.38
Avg Vol 3,903,985
Rel Vol (Sep 10) 0.59×
More stats
52W Low $72.30
Tight Wks 1 0 today
Base B2
SMA 200 $84.98
RS Line vs High -13.3%
RS Line Slope -2.1% ▼
Group Rank #25/58
ADR% 2.0%
ATR(14) $1.94 (2.2%)
Vol Pace (live) N/A
U/D Vol 0.84
A/D Days 17A / 14D
A/D Rating A
VDU Bars 0/10 d
Position in 52-week range 60thpercentile of the 52-week range
$72.30low
$96.29high

EW Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for EW.

Create Free Account

Technical Analysis Report Card

$EW · $86.77 · as of 2026-09-10 · multi-factor read
36
/ 100
Technicals 36/100
Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▬ Sideways / consolidating
Weekly ▬ Sideways / consolidating
Monthly ▬ Sideways / consolidating

Moving Averages

50-day$89.38 ↓
100-day$87.05 ↓
200-day$84.98 ↑
Bullish (50 > 200)

RSI (14)

Reading38.2 · Bearish

Bearish momentum — sellers in control.

MACD (12/26/9)

StateBearish
Histogram-0.598

Bearish — MACD below its signal line and below zero. Histogram contracting.

Bollinger Bands (20,2)

%B / Width1% · 7.6%
Squeeze — volatility compressing

Near the lower band — under pressure or oversold. Bands are squeezing — volatility is compressing, often a precursor to a sharp move.

Volume · Buyer vs Seller

Up/Down vol0.84 · Neutral
Rel volume0.59×

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

Support & Resistance

R · $87.32swing level
R · $89.28swing level
R · $93.43swing level
Price · $86.77now
S · $83.17swing level
S · $80.83swing level
S · $77.20swing level

Fibonacci · Uptrend swing

23.6%$91.62
38.2%$88.73
50.0% ◄ price here$86.39
61.8%$84.05
78.6%$80.73

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for EW — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Above 200-day MA50/200 bullishRS 8 (laggard)
Want this read in a legend's voice? Ask a Legend about EW
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 5 of 6 legends are Watching — building, not yet a confirmed buy.
Watch
Minervini C

Trend-template read: 6/10 pass; wait for the soft misses to improve.

Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $89.90, MA150 $85.03, MA200 $84.95
1.2 150-day MA > 200-day MAMA150 $85.03 vs MA200 $84.95
Failing evidence
1.8 RS rank ≥ 70 (prefer ≥ 85)RS rank 8
2. Quarterly EPS growth ≥ 25%From SEPA scan
6/10 checks
Avoid
O'Neil D

CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

Passing evidence
N: Near 52-week high or RS line new high6.6% below high | RS line new high: False
S: Base tightness (ATR% ≤ 4.5%)ATR% 2.08%
Failing evidence
L: RS rank ≥ 80 (IBD leadership)RS rank 8
C: Quarterly EPS acceleration ≥ 25%Data unavailable
2/8 checks
Watch
Weinstein C

Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.

Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $89.90 vs MA200 $84.95
Failing evidence
Volume expansion above averageVolume ratio 0.63x
Relative strength ≥ 60RS 8
5/7 checks
Watch
Livermore B

Pivotal-point read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$89.90
Distance from 52-week high6.6% below high
Failing evidence
Relative strengthRS 8
Volume vs average0.63x
3/6 checks
Watch
Darvas B

Box-theory read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$89.90
Distance from 52-week high6.6% below high
Failing evidence
Relative strengthRS 8
Volume vs average0.63x
3/6 checks
Watch
Wyckoff B

Supply-and-demand read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$89.90
Distance from 52-week high6.6% below high
Failing evidence
Relative strengthRS 8
Volume vs average0.63x
3/6 checks
Base & Breakout
Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

Latest candle: Bullish Engulfing — Today's up candle fully engulfs yesterday's down candle — a classic bullish reversal, strongest after a pullback to support.

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▼ Falling
95RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net -3 A
A: 12 D: 15 Net: -365 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini’s published criteria · 2/7 met
C 2/7 criteria
Separate score from the Minervini Trend Template (5/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ
Revenue growth ≥20% YoY +12%
Gross margin ≥30%
ROE ≥17%
RS rating ≥80 (leadership) 8
Stage 2 uptrend (Weinstein) Stage 2
Within 25% of 52W high -9.9%

Method Playbook

Trade it like O'Neil EXACT LEVELS · PRO
O'Neil D · Avoid — The deterministic methodology check is Avoid; wait until the blocking criteria are resolved.
Pivot
Pro level
Published-method rule: Use the proper base pivot or handle high after CANSLIM leadership and market-direction checks are satisfied.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Require a breakout through the pivot on volume at least 40% above average; the valid buy zone ends 5% above the pivot.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Use the setup's structural stop with a hard 7–8% maximum-loss ceiling from the actual entry.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Protect progress under constructive support such as the 21-day or 10-week line; a stop may ratchet higher but never lower.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit on the hard loss limit, a decisive support break, or a rule-based climax/distribution signal; a normal 20–25% advance is reviewed rather than assumed permanent.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

Forming Patterns (predictive — not confirmed)

Head & Shoulders bearish forming
75% built

Possible head & shoulders top — not confirmed. Watch for a daily close below ~75.59 (neckline) to confirm, with measured-move risk toward ~54.89. A push back above 93.91 weakens the pattern; reclaiming 96.29 invalidates it.

Confirms below 75.59
Invalidates at 96.29
Left Shoulder 89.60
Head 96.29
Right Shoulder 93.91
Neckline 75.59
Target 54.89

LS 89.60 / head 96.29 / RS 93.91, neckline ~75.59, vol_fading=yes

Predictive pattern recognition is educational — most forming structures never confirm. Wait for the confirmation level before treating this as a setup.

Pattern Analysis (historical)

53 setup score
RS Score 8
Trend template 5/8
The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

1/7 universals met
  • A relative-strength leader — not met RS rank 3 — laggard
  • Risk is defined — not met No stop — undefined risk
  • Asymmetric reward — partly met No target set
  • Clear of earnings — partly met Report date unknown
  • Not chasing (in range) — partly met Pivot distance unknown
  • Volume confirms — partly met 0.6× average — light
  • In a confirmed uptrend — met Stage 2 · Trend template 5/8
Why these seven? → The Universal Edge

Minervini Trend Template

5/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $86.77 vs SMA150 $85.13 / SMA200 $84.98
SMA 150 above SMA 200 SMA150 $85.13 vs SMA200 $84.98
SMA 200 trending up Slope +0.66 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $89.38
Price above SMA 50 $86.77 vs SMA50 $89.38
30%+ above 52-week low +20.0% from $72.30
Within 25% of 52-week high -9.9% from $96.29
RS score above 70 RS 8

Fundamentals

52W Range
60%
Mkt Cap SEC
50.0B
Rev YoY
+12%
EPS TTM
$1.83
P/E TTM
47.4x
Float
576M

Company

Company profile
Edwards Lifesciences Corporation
EW · NYSE · Health Technology · Medical Specialties

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
6/8
W. RS
59
W. Support
$76.49
W. Resist
$96.29
W. Patterns
Basing
Weekly Structure

Scan History

Sep 08: 53 (Trend Only)Sep 08: 54 (Trend Only)54
Sep 08
Trend Only ✓ Gate
54
Sep 08
Trend Only ✓ Gate
53 +0.1%

Get the full picture on EW

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial